Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-03-27
1990-02-20
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544366, A61K 31495, C07D40306, C07D40314
Patent
active
049026879
ABSTRACT:
The present invention provides novel piperazine derivatives useful as excitatory amino acid receptor antagonists and in treating a variety of associated nervous system disorders.
REFERENCES:
patent: 3536715 (1970-10-01), Hayao et al.
patent: 4746653 (1988-05-01), Hutchinson et al.
patent: 4761405 (1988-08-01), Rzeszotarski et al.
Derwent, 88-198230/29 Abstracting AU 8781-455.
Conrad Robert A.
Eli Lilly and Company
Shah Mukund J.
Shen Cecilia
Whitaker Leroy
LandOfFree
Excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1616291